Minnesota 2025-2026 Regular Session

Minnesota House Bill HF2047

Introduced
3/10/25  

Caption

Enrollee required to receive any rebates and discounts accrued directly or indirectly to health carriers.

Impact

If enacted, HF2047 could significantly alter the financial dynamics of prescription drug transactions in Minnesota. By requiring that rebates are integrated into the cost-sharing calculations at the point of sale, the bill seeks to lower the financial burden on consumers. This change may encourage more competitive pricing among health carriers and pharmacies, potentially leading to reduced costs for prescription medications statewide. Additionally, it aims to promote fairness by ensuring that enrollees do not bear excessive costs not reflective of the actual pricing dynamics influenced by rebates.

Summary

House File 2047 is a proposed bill focusing on healthcare regulations, specifically targeting how rebates and discounts from health carriers are processed. The bill mandates that any rebates or discounts associated with prescription drugs must be passed on to the enrollee at the point of sale, effectively reducing the out-of-pocket expenses for consumers. This initiative aims to enhance transparency and affordability in the healthcare system, ensuring that enrollees benefit directly from any negotiated pricing concessions received by health carriers.

Contention

However, HF2047 does face some contention, particularly regarding issues of confidentiality and the competitive implications for health carriers. The bill includes provisions that protect the confidentiality of rebate amounts, treating this information as proprietary. Opponents of the bill could argue that while the intention is to benefit consumers, strict confidentiality could lead to a lack of transparency regarding how pricing decisions are made and how much savings are actually passed on to enrollees. Additionally, there may be concerns regarding the ability of health carriers to adjust to this new regulatory environment without affecting the availability or quality of the services provided.

Companion Bills

MN SF2176

Similar To Requirements that an enrollee receive any rebates and discounts accrued directly or indirectly to health carriers

Previously Filed As

MN SF2176

Requirements that an enrollee receive any rebates and discounts accrued directly or indirectly to health carriers

MN HF1075

Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.

MN SF1877

Pharmacy benefit managers and health carriers usage of prescription drug rebates and other compensation requirement to benefit covered persons provision

MN LD1580

An Act to Prohibit Carriers and Pharmacy Benefits Managers from Using Spread Pricing

MN A311

Requires certification that persons directly or indirectly receiving State monies or privileges are not unauthorized aliens.

MN S1524

Requires certification that persons directly or indirectly receiving State monies or privileges are not unauthorized aliens.

MN HF4183

Requirements necessary for a health carrier to discontinue individual health plans eliminated, and state exception for a health carrier's uniform modification of coverage under an individual market health plan established.

MN SB1225

Pharmacies; cost sharing requirement; rebates

MN S3381

Prohibits pharmacy benefits managers from operating pharmacy practice sites directly or indirectly.

MN HB448

Apply prescription drug rebates to cost-sharing requirements

Similar Bills

No similar bills found.